2H-咪唑-2-酮，1,3-二氢-4-甲基-，CAS 登记号 1192-34-3，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 2H-咪唑-2-酮，1,3-二氢-4-甲基- 的 CAS 号：1192-34-3，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
2H-Imidazol-2-one, 1,3-dihydro-4-methyl- · CAS 1192-34-3 · C4H6N2O. UNII NS00023846.
| CAS Registry Number | 1192-34-3 |
|---|---|
| PubChem CID | 70935 |
| Molecular formula | C4H6N2O |
| IUPAC name | 4-methyl-1,3-dihydroimidazol-2-one |
| UNII (FDA) | NS00023846 |
| Molecular Weight | 98.10 |
|---|---|
| XLogP3 | -0.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 98.048012819 |
| Monoisotopic Mass | 98.048012819 |
| Topological Polar Surface Area | 41.1 |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (100%), H315 (100%), H319 (100%), H335 (100%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
1192-34-3; 1,3-Dihydro-4-methyl-2H-imidazol-2-one; EINECS 214-751-9; DTXSID60152337; NSC 186756; RefChem:72675; DTXCID7074828; 214-751-9; 4-Methyl-1H-imidazol-2(3H)-one; 4-methyl-1,3-dihydroimidazol-2-one; 4-Methyl-4-imidazolin-2-one; 4-methyl-1,3-dihydro-2H-imidazol-2-one; 2H-Imidazol-2-one, 1,3-dihydro-4-methyl-; MFCD00233011; 4-methyl-2,3-dihydro-1H-imidazol-2-one; 4-Methyl-2-(1H)imidazolone
CAS 1192-34-3; molecular formula C4H6N2O; molecular weight — g/mol.
1192-34-3, 1,3-Dihydro-4-methyl-2H-imidazol-2-one, EINECS 214-751-9, DTXSID60152337, NSC 186756, RefChem:72675.
Hazard statements reported: H302, H315, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.